Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
Prashant Kumar, Chris Bird, David A. Holland, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 20

Showing 20 citing articles:

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?
Christian Devaux, Pierre Pontarotti, Anthony Levasseur, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 6
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
Ryo Okuyama
Vaccines (2023) Vol. 11, Iss. 12, pp. 1737-1737
Open Access | Times Cited: 14
Sustained Immune Persistence Five Years Post-Completion of Four-Dose sIPV Vaccination
Kai Chu, Yurong Li, Liu Shen, et al.
(2025)
Closed Access
Two Recombinant Cytomegalovirus Antigens Formulated with the SPA14 Adjuvant System: Impact of Temperature, pH and Excipients on the Stability of each Antigen and Adjuvant Component
John M. Hickey, Ozan S. Kumru, François Dalençon, et al.
Journal of Pharmaceutical Sciences (2025)
Open Access
Sustained Immune Persistence Five Years Post-Completion of Four-Dose sIPV Vaccination
Kai Chu, Yurong Li, Sheng Liu, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 253-253
Open Access
Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies
Jonathan Kantor, Robert Carlisle, Samantha Vanderslott, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Enteroviruses Activate Cellular Innate Immune Responses Prior to Adaptive Immunity and Tropism Contributes to Severe Viral Pathogenesis
Jonathan Coffman
Microorganisms (2025) Vol. 13, Iss. 4, pp. 870-870
Open Access
Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges
Prashant Kumar, David A. Holland, Kathryn Secrist, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 609-609
Open Access | Times Cited: 2
Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate
Prashant Kumar, Michael Wang, Ozan S. Kumru, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 30, pp. 103-121
Open Access | Times Cited: 5
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines
Ozan S. Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Vaccine (2023) Vol. 41, Iss. 44, pp. 6502-6513
Open Access | Times Cited: 4
Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months
Guang-Wei Feng, Ming Shao, Jianfeng Wang, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 123-123
Open Access | Times Cited: 1
Immune persistence after different polio sequential immunization schedules in Chinese infants
Ting Zhao, Jing Li, Teng Huang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Advancements in Human Vaccine Development: From Traditional to Modern Approaches
Mourad Aribi
IntechOpen eBooks (2024)
Closed Access | Times Cited: 1
Threat of resurgence or hope for global eradication of poliovirus?
Carla Y. Kim, Bernadeth Lyn C. Piamonte, Rebecca Allen, et al.
Current Opinion in Neurology (2023) Vol. 36, Iss. 3, pp. 229-237
Closed Access | Times Cited: 3
Animal cell culture in vaccine production
Kajal Sandhu, Sudipa Bhadra, Sankarakuttalam Chockalingam, et al.
Elsevier eBooks (2024), pp. 115-139
Closed Access


Journal of Medicinal and Chemical Sciences (2024) Vol. 7, Iss. 6
Open Access
Evaluating the Compatibility of Three Aluminum Salt-Adjuvanted Recombinant Protein Antigens (Trivalent NRRV) Combined with a Mock Trivalent Sabin-IPV Vaccine: Analytical and Formulation Challenges
Prashant Kumar, Atsushi Hamana, Chris Bird, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1102-1102
Open Access
Correlating physicochemical and biological properties to define critical quality attributes of a recombinant AAV vaccine candidate
Prashant Kumar, M. Wang, Ozan S. Kumru, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Immune Persistence after Different Polio Sequential Immunization Schedules in Chinese Infants
Jingsi Yang, Ting Zhao, Jing Li, et al.
Research Square (Research Square) (2023)
Open Access
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
Ozan S. Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access
Page 1

Scroll to top